GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » PB Ratio

DVHGF (Devonian Health Group) PB Ratio : 2.02 (As of Mar. 15, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-15), Devonian Health Group's share price is $0.14375. Devonian Health Group's Book Value per Share for the quarter that ended in Oct. 2024 was $0.07. Hence, Devonian Health Group's PB Ratio of today is 2.02.

The historical rank and industry rank for Devonian Health Group's PB Ratio or its related term are showing as below:

DVHGF' s PB Ratio Range Over the Past 10 Years
Min: 0.75   Med: 2.02   Max: 7.07
Current: 1.89

During the past 11 years, Devonian Health Group's highest PB Ratio was 7.07. The lowest was 0.75. And the median was 2.02.

DVHGF's PB Ratio is ranked better than
56.8% of 1280 companies
in the Biotechnology industry
Industry Median: 2.33 vs DVHGF: 1.89

During the past 12 months, Devonian Health Group's average Book Value Per Share Growth Rate was 2.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -6.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 5.90% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Devonian Health Group was 83.60% per year. The lowest was -26.10% per year. And the median was 1.20% per year.

Back to Basics: PB Ratio


Devonian Health Group PB Ratio Historical Data

The historical data trend for Devonian Health Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group PB Ratio Chart

Devonian Health Group Annual Data
Trend Jun15 Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.85 2.25

Devonian Health Group Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.05 3.19 2.56 2.25 1.55

Competitive Comparison of Devonian Health Group's PB Ratio

For the Biotechnology subindustry, Devonian Health Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's PB Ratio falls into.



Devonian Health Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Devonian Health Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Oct. 2024)
=0.14375/0.071
=2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Devonian Health Group  (OTCPK:DVHGF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Devonian Health Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Devonian Health Group Business Description

Traded in Other Exchanges
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines